Agilent Early Career Professor Award
Agilent congratulates Carl DeSelm, winner of the 2020 Agilent Early Career Professor Award
2020 Focus: Contributions to the development of breakthrough live cell analysis technologies for measuring cellular responses to chemical/pharmaceutical treatments and genetic manipulations, including those that could advance cell-based therapies.
Carl DeSelm, M.D., Ph.D.
Dept. of Radiation Oncology
Washington University in St. Louis School of Medicine
Dr. DeSelm received a Bachelor of Science in Genetics, Cell, and Developmental Biology from Dartmouth College in 2004 and subsequently obtained his M.D. and Ph.D. degrees from Washington University in St. Louis in 2012. As a PhD student, Dr. DeSelm described a secretory pathway in the bone resorbing osteoclast that utilizes authophagy pathway proteins, and characterized the role of IL-17 in the pathogenesis of osteoporosis. His work led to a patent for a new therapy for osteoporosis. He then completed an Internship in Internal Medicine at Barnes-Jewish Hospital, St. Louis in 2013 followed up by a Residency in Radiation Oncology at Memorial Sloan Kettering Cancer Center, in 2017 where he got involved in the nascent field of CAR-T cell therapy by working in the laboratory of Dr. Michel Sadelain.
Dr. DeSelm joined the Washington University faculty in June 2018 as an assistant professor of Radiation Oncology with a laboratory in the Bursky Center for Human Immunotherapy and Immunology Programs. His current research and clinical interests focus on the engineering and clinical development of a new class of cell immunotherapy, engineering Antigen Presenting Cells (APC). This approach has the potential to address some of the limitations of the CAR T Cell therapy in the treatment of solid tumors. Likewise, he is interested in understanding and leveraging the role that radiation treatment can have to synergize with CAR-APC immunotherapy.
His outstanding work has been recognized by a number of awards, including the Young Investigator Award: American Society for Bone and Mineral Research in 2009, the Merit Award: Division of Biology and Biomedical Sciences, Washington University in St. Louis in 2011, the Needleman Pharmacology Award: Washington University in St. Louis in 2012, the Holman Research Pathway in 2017, the Early Independence Award from the NIH Director in 2018, and the Pancreatic Cancer SPORE Career Enhancement Program Award in in 2019.
Purpose of Award
- Promote and encourage excellent research enabling measurements of importance to Agilent Technologies and the world
- Establish strong collaborative relationships between Agilent researchers and leading professors early in their career
- Build the prominence of Agilent as a sponsor of university research
- Significant original research contributions enabling measurements of importance to Agilent Technologies and the world
- Outstanding potential for future research
- Alignment with specified award focus
- Professor (see FAQ) completed Ph.D. or residency (in case of M.D.'s or M.D.- Ph.D.'s) not earlier than 10 years prior to January of the corresponding award year
- An unrestricted award of a total of $100,000 in support of the professor's research paid to the university in two annual installments
- Option to use all or part of award to obtain Agilent products at 50% discount
- Option to accelerate payments to facilitate procurement of equipment with list price over $100k
- Engraved plaque commemorating award
- Recognition on Agilent's website
2021 ECPA Award
- Award focus, instructions and deadlines will be posted in October 2020.